News Search Results
18 Jun, 2026, 08:16 GMT Health and Wellness Market Size to Hit $12.9 Trillion by 2031 Growing at a CAGR of 10.9%: Allied Market Research
Food: The health and wellness of food is estimated to be the fastest growing segment with a CAGR of 11.6% during the forecast period. The COVID-19 pandemic massively increases consumer demand for vitamins, minerals and dietary supplements which support immune health. Global adoption of functional
More news about: Allied Market Research
12 Jun, 2026, 08:00 GMT The Galien Foundation Honours Leaders in Life Sciences Innovation with the 2026 Prix Galien UK Awards
Bingham, Former Chair of the UK Government's Vaccine Taskforce, whose efforts were instrumental in leading the UK's sourcing and manufacturing of a COVID-19 vaccine. Kate has spent over 30 years at SV Health Investors, building and investing in early-stage biotech companies across the UK, EU, and US, contributing
More news about: The Galien Foundation
10 Jun, 2026, 23:24 GMT /C O R R E C T I O N -- The Galien Foundation/
University of LiverpoolLiverpool's COVID-19 Trio: ISARIC (clinical characterisation), SMART (testing) and AGILE (trials)
More news about: The Galien Foundation
09 Jun, 2026, 22:23 GMT Teen-Founded Nonprofit Busy Buzzy Bots Reaches 11,000+ Kids Through STEM Education--and It Is Just Getting Started
Addressing Community Needs With BBBDuring the COVID-19 pandemic in 2020, Bay Area students Saahithi Madhuvarsu and Saaketh Madhuvarsu identified a gap in STEM accessibility affecting underserved K-12 students.
More news about: Busy Buzzy Bots
08 Jun, 2026, 12:00 GMT AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026
infections (30% vs 12%) and any-grade COVID-19 (36% vs 11%) were reported in the epcoritamab arm. Grade 5 treatment-emergent adverse events (TEAEs) occurred in 17% vs 6% (exposure-adjusted, 1.5 vs 1.8 per 100 pt-mo) and were largely attributable to grade 5 COVID-19 (9% vs 2%).2*OUS
More news about: AbbVie
04 Jun, 2026, 15:59 GMT Roche rapidly develops a PCR test for Ebola within six days as rare Bundibugyo virus drives urgent need for detection
virus is the latest in a series of rapid-response molecular solutions for infectious diseases produced at scale by Roche, including Mpox in 2022, Covid-19 in 2020, ZIKA in 2015, Ebola (Zaire species) in 2014/15, MERS in 2012, H1N1 swine flu in 2009, H5N1 bird flu in 2005 and SARS in 2003. Most recently,
More news about: Roche
03 Jun, 2026, 16:04 GMT RedHill Biopharma Advancing Opaganib Options For Ebola Virus Disease Outbreak
platform Opaganib EVD rationale (analogous to EVD treatment pathway):Phase 3 clinical antiviral activity (severe COVID-19) showing2: 70.2% mortality reduction with opaganib given as add-on to best available standard of care
More news about: RedHill Biopharma Ltd.
03 Jun, 2026, 15:43 GMT Point of Care Testing Market Poised for US$ 64.8 Bn Valuation by 2031, Growing at 7.5% CAGR, New Report by Wissen Research
breakthrough molecular diagnostics platform that is designed to deliver highly sensitive, multiplex RT-PCR testing for Influenza A, Influenza B and COVID-19 directly from a swab sample in approximately six to ten minutes.In March 2026, Abbott Laboratories and Flatiron Health, a leading healthtech
More news about: Wissen Research LLC
01 Jun, 2026, 20:00 GMT EUROPEAN COMMISSION APPROVES AMGEN'S IMDYLLTRA® FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
fatal infections, have been reported in patients treated with IMDYLLTRA®. The most frequent infections include pneumonia, urinary tract infection, COVID‑19, upper respiratory tract infection, respiratory tract infection, candida infection, oral candidiasis and nasopharyngitis. Patients should be monitored
More news about: Amgen
29 May, 2026, 12:00 GMT AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia
common serious adverse reactions (≥2%) were COVID-19, including COVID-19 pneumonia (9%), second primary malignancies (2.7%) and neutropenia (2.1%). Fatal adverse events occurred in 3.4% of patients. The most common fatal adverse events included COVID-19 and COVID-19 pneumonia.About the GLOW StudyThe
More news about: AbbVie
28 May, 2026, 14:15 GMT Remote Patient Monitoring Market to Reach US$ 117.9 Bn by 2033 Expands Amid Digital Healthcare Transformation - Persistence Market Research
expansion of telehealth and virtual healthcare services is another key driver for the remote patient monitoring market. Following the COVID-19 pandemic, healthcare providers accelerated digital transformation initiatives to maintain continuity of care while reducing unnecessary hospital visits.
More news about: Persistence Market Research Pvt. Ltd.
20 May, 2026, 20:00 GMT Frost & Sullivan: Trade Corridor-Resilient, AI-integrated Supply Chains Will Define Competitive Advantage Through 2027
resilience-focused operating models will continue to accelerate over the next several years.The research highlights how disruptions ranging from the COVID-19 pandemic and the Russo-Ukrainian war to escalating US tariff measures and the ongoing Middle East conflict have exposed vulnerabilities across maritime
More news about: Frost & Sullivan
19 May, 2026, 15:30 GMT Portable Ultrasound Scanner Market Size to Hit USD 4.1 Billion, by 2032 at 5.7% CAGR: Allied Market Research
ultrasound imaging within previously underserved, clinical environments. The COVID-19 pandemic demand for portable ultrasound particularly for lung assessment and as a bedside monitoring tool but also COVID-19 disease progression without the need to transport potentially infected patients has
More news about: Allied Market Research
19 May, 2026, 11:00 GMT Dental Tourism Market to Hit $21.5 Billion by 2031, Growing at 13.9% CAGR: Allied Market Research
aspects of the procedure. Post-COVID Demand Resurgence & Digital Consultation Infrastructure: The large-scale disruption caused by the COVID-19 epidemic to dental tourism procedure volumes from the end of 2019 – international travel restrictions, patient reluctance to fly, infection precaution
More news about: Allied Market Research
14 May, 2026, 15:41 GMT Mental Health Market to Reach $537.97 Billion, Globally, by 2030 at 3.5% CAGR: Allied Market Research
This growth signals a global consensus on the size and ferocity of the mental wellbeing disaster speeded up in no small part via way of means of Covid 19. WHO states that in 2020 alone, over 264 million people of all ages suffer from depression, and thereby is the leading cause of disability worldwide
More news about: Allied Market Research
13 May, 2026, 14:52 GMT Supply Chain Management Market to Reach USD 93.9 Billion, Globally, by 2034 at 10.9% CAGR: Allied Market Research
manufacturing expansion has further intensified the need for advanced digital supply chain tools. Additionally, disruptions from events such as the COVID-19 pandemic, geopolitical tensions, and raw material shortages have highlighted the importance of resilient and agile supply chains, accelerating market
More news about: Allied Market Research
12 May, 2026, 21:00 GMT Mountain Province Diamonds Announces First Quarter Financial Results for 2026
forward-looking statements include the development of operation hazards which could arise in relation to COVID-19, including, but not limited to protocols which may be adopted to reduce the spread of COVID-19 and any impact of such protocols on Mountain Province's business and operations, variations in ore
More news about: Mountain Province Diamonds Inc.
12 May, 2026, 11:00 GMT New Data Show Gaps in Antiviral Pipeline Against High-Risk Viral Threats
compounds for Non-COVID-19 indications (reaching 65 versus 29 previously) during the past 18 months, some of them resulting from the work of the NIH-funded AViDD centers. The number of investigational clinical compounds has remained relatively stable for both COVID-19 and Non-COVID-19 viral indications
More news about: INTREPID Alliance
11 May, 2026, 04:01 GMT Millions of 'pandemic pets' are reaching midlife, but owners could miss a crucial opportunity to improve their pet's healthspan
MONTPELLIER, France, May 11, 2026 /PRNewswire/ -- Millions of dogs and cats adopted during the COVID-19 pandemic are now reaching midlife2,4 - a life stage recognised in the latest veterinary science as a critical window for long-term health3
More news about: Royal Canin
07 May, 2026, 13:51 GMT MENARINI GROUP: THOMAS CUENI APPOINTED NEW MEMBER OF THE BOARD
forging cross-sector initiatives to address access to treatment for chronic diseases and shape policies tackling global health challenges such as the COVID-19 pandemic. In the field of anti-microbial resistance, he established the nearly USD 1 billion AMR Action Fund to support the development of new antibiotics.
More news about: Menarini Industrie Farmaceutiche Riunite
06 May, 2026, 14:01 GMT Escape Room Market Expected to Reach USD 31.0 Billion by 2032, at a CAGR of 14.8%: Allied Market Research
time. Motion sensors, dynamic lighting, spatial audio systems, and interactive props are collectively raising the bar for experiential quality. The COVID-19 pandemic accelerated the shift to virtual escape room formats, which now serve as a permanent, scalable product extension enabling operators to reach
More news about: Allied Market Research
04 May, 2026, 21:04 GMT Cellenkos Announces FDA Clearance of Investigational New Drug (IND) Application for Phase 1b/ 2a Trial of CK0802 in Steroid-Refractory Graft-versus-Host Disease (GVHD)
Results from a randomized, placebo-controlled trial demonstrate that CK0802 Tregs are a safe and highly effective treatment for critically ill COVID-19 ARDS patients, requiring mechanical ventilation and vasopressor support, thought to be driven by severe "cytokine storm" inflammation, like that seen
More news about: Cellenkos, Inc.
29 Apr, 2026, 15:34 GMT Global Light Therapy Market Size Will Reach $802.7 Million by 2031, Growing at a CAGR of 4.4% -- Allied Market Research
as skin diseases affect 900 million people worldwide (World Health Organisation). Moreover, a worldwide rise in mental disorders exacerbated by the COVID-19 pandemic has accelerated the use of light therapy among people with seasonal affective disorder (SAD), major depressive disorder, or disrupted circadian
More news about: Allied Market Research
27 Apr, 2026, 15:04 GMT Zensar registered 3.1% YoY revenue growth in reported currency for full year FY26
unauthorized use of intellectual property and general economic conditions affecting the industry.In addition to the foregoing, global pandemics like COVID-19 may pose an unforeseen, unprecedented, unascertainable, and constantly evolving risk(s), inter-alia, to us, our customers, delivery models, vendors,
More news about: Zensar Technologies
23 Apr, 2026, 05:18 GMT FMCG Market to Reach $18,939.4 Billion by 2031 at 5.1% CAGR - Allied Market Research
recently, consumers are paying serious attention to hygiene, nutritional quality and general transparency of products, trends that got a major push during COVID-19 pandemic - both before & after. The behavioral changes have increased the demand for healthcare, personal care and organic food & beverage
More news about: Allied Market Research